|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nana-Sinkam SP and Powell CA: Molecular
biology of lung cancer: Diagnosis and management of lung cancer,
3rd ed: American College of Chest Physicians evidence-based
clinical practice guidelines. Chest. 143 5 Suppl:e30S–e39S. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bhargava A, Bunkar N, Aglawe A, Pandey KC,
Tiwari R, Chaudhury K, Goryacheva IY and Mishra PK: Epigenetic
biomarkers for risk assessment of particulate matter associated
lung cancer. Curr Drug Targets. 19:1127–1147. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Peng Z, Pan L, Niu Z, Li W, Dang X, Wan L,
Zhang R and Yang S: Identification of microRNAs as potential
biomarkers for lung adenocarcinoma using integrating genomics
analysis. Oncotarget. 8:64143–64156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nohata N, Hanazawa T, Kinoshita T, Okamoto
Y and Seki N: MicroRNAs function as tumor suppressors or oncogenes:
Aberrant expression of microRNAs in head and neck squamous cell
carcinoma. Auris Nasus Larynx. 40:143–149. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang L, Liang H, Wang Y, Gao S, Yin K, Liu
Z, Zheng X, Lv Y, Wang L, Zhang CY, et al: MiRNA-203 suppresses
tumor cell proliferation, migration and invasion by targeting Slug
in gastric cancer. Protein Cell. 7:383–387. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng C, Sun P, Hu J, Feng H, Li M, Liu G,
Pan Y, Feng Y, Xu Y, Feng K, et al: miRNA-556-3p promotes human
bladder cancer proliferation, migration and invasion by negatively
regulating DAB2IP expression. Int J Oncol. 50:2101–2112. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hu X, Zhang M, Miao J, Wang X and Huang C:
miRNA-4317 suppresses human gastric cancer cell proliferation by
targeting ZNF322. Cell Biol Int. Sep 7–2017.(Epub ahead of
print).
|
|
11
|
Li Y, Zhang H, Dong Y, Fan Y, Li Y, Zhao
C, Wang C, Liu J, Li X, Dong M, et al: MiR-146b-5p functions as a
suppressor miRNA and prognosis predictor in non-small cell lung
cancer. J Cancer. 8:1704–1716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang D, Cao Q, Qu M, Xiao Z, Zhang M and
Di S: MicroRNA-616 promotes the growth and metastasis of non-small
cell lung cancer by targeting SOX7. Oncol Rep. 38:2078–2086. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Green MR, Vicente-Dueñas C, Alizadeh AA
and Sánchez-García I: Hit-and-run lymphomagenesis by the Bcl6
oncogene. Cell Cycle. 13:1831–1832. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kojima S, Hatano M, Okada S, Fukuda T,
Toyama Y, Yuasa S, Ito H and Tokuhisa T: Testicular germ cell
apoptosis in Bcl6-deficient mice. Development. 128:57–65.
2001.PubMed/NCBI
|
|
15
|
Nola S, Sin S, Bonin F, Lidereau R and
Driouch K: A methodological approach to unravel organ-specific
breast cancer metastasis. J Mammary Gland Biol Neoplasia.
17:135–145. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yan H, Zhao M, Huang S, Chen P, Wu WY,
Huang J, Wu ZS and Wu Q: Prolactin inhibits BCL6 expression in
breast cancer cells through a microRNA-339-5p-dependent pathway. J
Breast Cancer. 19:26–33. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamada Y, Sakai N, Sogabe S, Ida K, Oki H,
Sakamoto K, Lane W, Snell G, Iida M, Imaeda Y, et al: Discovery of
a B-cell lymphoma 6 protein-protein interaction inhibitor by a
biophysics-driven fragment-based approach. J Med Chem.
60:4358–4368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rivera MP: Lung cancer in women:
Differences in epidemiology, biology, histology, and treatment
outcomes. Semin Respir Crit Care Med. 34:792–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Han R, Chen Z, Fu M, Kang J, Li K,
Li L, Chen H and He Y: A transcriptional miRNA-gene network
associated with lung adenocarcinoma metastasis based on the TCGA
database. Oncol Rep. 35:2257–2269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang YL, Chen CM, Wang XM and Wang L:
Effects of miR-339-5p on invasion and prognosis of hepatocellular
carcinoma. Clin Res Hepatol Gastroenterol. 40:51–56. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu ZS, Wu Q, Wang CQ, Wang XN, Wang Y,
Zhao JJ, Mao SS, Zhang GH, Zhang N and Xu XC: MiR-339-5p inhibits
breast cancer cell migration and invasion in vitro and may be a
potential biomarker for breast cancer prognosis. BMC Cancer.
10:5422010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou C, Liu G, Wang L, Lu Y, Yuan L, Zheng
L, Chen F, Peng F and Li X: MiR-339-5p regulates the growth, colony
formation and metastasis of colorectal cancer cells by targeting
PRL-1. PLoS One. 8:e631422013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Jansson MD, Damas ND, Lees M, Jacobsen A
and Lund AH: miR-339-5p regulates the p53 tumor-suppressor pathway
by targeting MDM2. Oncogene. 34:1908–1918. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu L, Chen Y, Dutra-Clarke M, Mayakonda A,
Hazawa M, Savinoff SE, Doan N, Said JW, Yong WH, Watkins A, et al:
BCL6 promotes glioma and serves as a therapeutic target. Proc Natl
Acad Sci USA. 114:3981–3986. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu L, Feng H, Jin S, Tan M, Gao S, Zhuang
H, Hu Z, Wang H, Song Z and Lin B: High expressions of BCL6 and
Lewis y antigen are correlated with high tumor burden and poor
prognosis in epithelial ovarian cancer. Tumour Biol.
39:10104283177116552017.doi: 10.1177/1010428317711655. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu Z, Wang S, Zhu J, Yang Q, Dong H and
Huang J: MicroRNA-544 down-regulates both Bcl6 and Stat3 to inhibit
tumor growth of human triple negative breast cancer. Biol Chem.
397:1087–1095. 2016. View Article : Google Scholar : PubMed/NCBI
|
